Release no. 25/2011

Copenhagen and Oslo, 2011-12-28 11:33 CET (GLOBE NEWSWIRE) --

The financial calendar for Affitech A/S, (NASDAQ OMX: AFFI) for 2012 is as
follows


29th March, 2012 Financial Result 2011


26th April, 2012 Annual General Meeting


24th May, 2012 Interim financial report for 1st quarter 2012


30th August, 2012 Interim financial report for 2nd quarter 2012


22nd November, 2012 Interim financial report for 3rd quarter 2012



For more information please contact

Randi Krogsgaard, Director Corporate Communications & IR

Tel # +45 2320 1001, e-mail: [email protected]



About Affitech

Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic
antibody company based in Copenhagen, Denmark with R&D facilities in Oslo,
Norway. The company utilizes a range of proprietary antibody technologies for
the discovery of fully human antibodies for application in oncology,
inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is
Affitech’s premier discovery engine for the isolation of lead antibodies to
cell surface molecules in situ. Several of the Company's proprietary product
candidates were generated by CBAS™. Further information is available at
www.affitech.com.